SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 7.58 |
| Enterprise Value ($M) | 5.11 |
| Book Value ($M) | 19.73 |
| Book Value / Share | 0.65 |
| Price / Book | 0.38 |
| NCAV ($M) | 12.22 |
| NCAV / Share | 0.40 |
| Price / NCAV | 0.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.27 |
| Current Ratio | 3.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 18.15 |
| Assets | 25.66 |
| Liabilities | 5.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 50.32 |
| Operating Income | 0.25 |
| Net Income | 0.11 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.94 |
| Cash from Investing | -0.55 |
| Cash from Financing | -0.03 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K __ __________ | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| IGXT – IntelGenx Technologies Corp. | ILIM – IL2M International Corp |
| IMUC – EOM Pharmaceuticals Holdings, Inc. | INFIQ – Infinity Pharmaceuticals, Inc. |
| INRLF – Valneva SE |
Financial data and stock pages provided by
Fintel.io